Multistage Polymers

A multi-stage polymer with acrylate-rich and carbosiloxane-rich stages addresses compatibility issues, ensuring stable formulations and improved sensory properties in personal care and home care products.

JP7749551B2Active Publication Date: 2025-10-06DOW GLOBAL TECHNOLOGIES LLC +1
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2022524214
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-11-21
Filing Date
2020-11-18
Publication Date
2025-10-06
Estimated Expiration
2040-11-18

AI Technical Summary

Technical Problem

Silicone-containing polymers face compatibility issues with other components in coating, personal care, and home care formulations, leading to phase separation during storage.

Method used

A multi-stage polymer comprising an acrylate-rich stage with monoethylenically unsaturated nonionic acrylate-rich monomers and a carbosiloxane-rich stage with specific carbosiloxane monomers, tailored to enhance compatibility and formulation flexibility.

Benefits of technology

The multi-stage polymer improves compatibility with other ingredients, preventing phase separation and enhancing sensory properties in personal care and home care formulations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007749551000001
    Figure 0007749551000001
  • Figure 0007749551000002
    Figure 0007749551000002
  • Figure 0007749551000003
    Figure 0007749551000003
Patent Text Reader

Abstract

(a)C 1~22 a multi-stage monomer having (a) an acrylate-rich stage comprising structural units of an alkyl (meth)acrylate and a first carbosiloxane monomer of formula (I); and (b) a carbosiloxane-rich stage comprising structural units of a second carbosiloxane monomer of formula (I), wherein a is 0 to 3, d is 0 or 1, and R 1 is hydrogen, C 1~10 R is selected from alkyl groups and aryl groups; 2 is hydrogen, and C 1~10 alkyl groups, and R 8 is a —O—Si(CH3)3 group, and Y is selected from formulas (II), (III), and (IV), where R 4 and R 6 is selected from hydrogen and a methyl group, and R 3 and R 5 is C 1~10 is an alkylene group, and R 7 is C 1~10 A multi-stage polymer is provided wherein b is an alkyl group, b is 0 to 4, c is 0 or 1, and the first and second carbosiloxane monomers of formula (I) are the same or different.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates to multi-stage polymers. In particular, the present invention relates to a multi-stage polymer comprising: (a) C 1~22 1. A multi-stage polymer comprising (a) an acrylate-rich stage comprising structural units of a monoethylenically unsaturated nonionic acrylate-rich stage monomer selected from alkyl (meth)acrylates and mixtures thereof, and structural units of a first carbosiloxane monomer of formula (I); and (b) a carbosiloxane-rich stage comprising structural units of a second carbosiloxane monomer of formula (I), wherein a is 0 to 3, d is 0 or 1, and R 1 is hydrogen, C 1~10 R is selected from alkyl groups and aryl groups; 2 is hydrogen, and C 1~10 alkyl groups, and R 8 is a —O—Si(CH3)3 group, and Y is selected from formulas (II), (III), and (IV), where R 4 and R 6 is selected from hydrogen and a methyl group, and R 3 and R 5 is C 1~10 is an alkylene group, and R 7 is C 1~10 is an alkyl group, b is 0 to 4, c is 0 or 1, and the first carbosiloxane monomer of formula (I) and the second carbosiloxane monomer of formula (I) are the same or different.

[0002] Silicone-containing polymers have been proposed and used in the coating, personal care, and home care industries.In coating formulations, silicone-containing polymers offer the potential for general surface property modification, as these polymers can impart water and oil repellency, stain resistance, barrier properties, surfactant properties, and lubricity to the formulated coatings.In personal care formulations, silicone-containing polymers provide improved performance and desirable sensory properties to the formulated products.

[0003] However, the attempt to design silicone-containing polymer and incorporate it into formulated product faces serious problems.Silicone-containing polymer is often incompatible with other components of formulated product, such as polar polymer and other components that are typically contained in coating formulation and home care composition and personal care composition.Therefore, auxiliary additives are typically used to make silicone-containing polymer compatible with other components in formulated product, and prevent the phase separation of main components during storage.

[0004] An approach to providing silicone-containing polymers that offer improved compatibility with cosmetic formulations is disclosed by Blankenburg et al. in U.S. Patent No. 6,403,074. In U.S. Patent No. 6,403,074, Blankenburg et al. disclose water-soluble or water-dispersible polymers obtained by subjecting (a) ethylenically unsaturated monomers to free radical polymerization in the presence of (b) a polyalkylene oxide-containing silicone derivative of the following formula: [ka] .

[0005] Nevertheless, there remains a need for new silicone-containing polymers that offer formulation flexibility and compatibility for use in a variety of coating, personal care, and home care formulations.

[0006] The present invention relates to a multi-stage polymer comprising: (a) from 38 to less than 100 weight percent, based on the weight of the acrylate-rich stage, of structural units of a monoethylenically unsaturated nonionic acrylate-rich stage monomer, wherein the monoethylenically unsaturated nonionic acrylate-rich stage monomer is selected from the group consisting of C 1~22 structural units selected from the group consisting of alkyl (meth)acrylates and mixtures thereof; and from greater than 0 to 50 wt. % structural units of a first carbosiloxane monomer of formula (I), based on the weight of the acrylate-rich stage; [ka] an acrylate-rich stage comprising: 0 to 10 wt. %, based on the weight of the acrylate-rich stage, structural units of an acrylate-rich stage monomer of a monoethylenically unsaturated carboxylic acid; and 0 to 2 wt. %, based on the weight of the acrylate-rich stage, structural units of a multiethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule; and a carbosiloxane-rich stage comprising: 0 to 90 wt. %, based on the weight of the carbosiloxane-rich stage, structural units of a vinyl monomer; and 10 to 100 wt. %, based on the weight of the carbosiloxane-rich stage, structural units of a second carbosiloxane monomer of formula (I), [ka] , In the formula, a is 0 to 3, d is 0 or 1, and each R 1 are independently hydrogen, C 1~10 alkyl groups, and aryl groups, and each R 2 are independently hydrogen, and C 1~10 alkyl groups, and each R 8 is a —O—Si(CH3)3 group, and Y is selected from the group consisting of formulas (II), (III), and (IV), [ka] In the formula, each R 4 and R 6 are independently selected from the group consisting of hydrogen and a methyl group, and each R 3 and R 5 independently, C 1~10 is an alkylene group, and each R 7 independently, C 1~10 is an alkyl group, b is 0 to 4, c is 0 or 1, and the first carbosiloxane monomer of formula (I) and the second carbosiloxane monomer of formula (I) are the same or different, providing a multi-stage polymer.

[0007] The present invention provides a composition comprising the multistage polymer of the present invention, wherein the composition is selected from the group consisting of a personal care formulation, a home care formulation, a coating, an oil field maintenance fluid, a civil engineering maintenance fluid, a construction formulation, and a pharmaceutical preparation. DETAILED DESCRIPTION OF THE INVENTION

[0008] Unique multi-stage polymers have been identified for use in a variety of compositions in which the desirable properties imparted through the incorporation of silicone-containing polymers can be tailored to promote compatibilization with other ingredients in such compositions.

[0009] Unless otherwise indicated, ratios, percentages, parts, etc. are by weight.

[0010] The term "aesthetic properties" as used herein and in the appended claims in connection with personal care formulations refers to visual and tactile sensory properties (e.g., smoothness, adhesion, lubricity, texture, color, clarity, opacity, uniformity).

[0011] The term "building block" as used herein and in the appended claims refers to the remainder of the indicated monomer in the claimed polymer; thus, a building block of n-butyl acrylate is exemplified as follows: [ka] where the dotted lines represent points of attachment to the polymer backbone.

[0012] The term "(meth)acrylic acid" as used herein and in the appended claims is intended to serve as a generic expression encompassing both acrylic acid and methacrylic acid.

[0013] The term "(meth)acrylate" as used herein and in the appended claims is intended to serve as a generic term encompassing both acrylates and methacrylates.

[0014] The term "cosmetically acceptable" as used in this specification and the appended claims refers to ingredients typically used for topical application to the skin, and is intended to emphasize that materials that are toxic when present in amounts typically found in skin care compositions are not contemplated as part of the present invention.

[0015] Preferably, the multi-stage polymer of the present invention comprises (a) an acrylate-rich stage (preferably 60 to 95 wt%, more preferably 65 to 90 wt%, even more preferably 70 to 85 wt%, and most preferably 75 to 82 wt%), based on the weight of the multi-stage polymer, of which 38 to less than 100 wt% (preferably 44 to 99.39 wt%, more preferably greater than 77 to 98.73 wt%, even more preferably 78.9 to 97.95 wt%, and most preferably 82.17 to 94.68 wt%), based on the weight of the acrylate-rich stage, are structural units of monoethylenically unsaturated nonionic acrylate-rich stage monomers, wherein the monoethylenically unsaturated nonionic acrylate-rich stage monomers are 1~22 structural units selected from the group consisting of alkyl (meth)acrylates and mixtures thereof, and from greater than 0 to 50 wt. % (preferably from 0.1 to 50 wt. %, more preferably from 0.5 to less than 20 wt. %, even more preferably from 1 to 19 wt. %, and most preferably from 4 to 16 wt. %) of structural units of a first carbosiloxane monomer of formula (I), based on the weight of the acrylate-rich stage; [ka] , % (preferably 0.01 to 1 wt %, more preferably 0.02 to 0.5 wt %, even more preferably 0.05 to 0.1 wt %, most preferably 0.07 to 0.08 wt %), based on the weight of the acrylate-rich stage, of structural units of an acrylate-rich stage monomer of a monoethylenically unsaturated carboxylic acid, and 0 to 2 wt % (preferably 0.01 to 1 wt %, more preferably 0.02 to 0.5 wt %, even more preferably 0.05 to 0.1 wt %, most preferably 0.07 to 0.08 wt %), based on the weight of the acrylate-rich stage, of structural units of a multiethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule; and (b) an acrylate-rich stage (preferably 0.5 to 5 wt %, more preferably 0.75 to 2.5 wt %, even more preferably 1 to 2 wt %, and most preferably 1.25 to 1.75 wt %), based on the weight of the multistage polymer. 5 to 40 wt%, more preferably 10 to 35 wt%, even more preferably 15 to 30 wt%, and most preferably 18 to 25 wt% of a carbosiloxane-rich stage comprising 0 to 90 wt% (preferably 10 to less than 50 wt%, more preferably 12.5 to 30 wt%, even more preferably 15 to 25 wt%, and most preferably 19 to 21 wt%) of structural units of vinyl monomers, based on the weight of the carbosiloxane-rich stage, and 10 to 100 wt% (preferably greater than 50 to 90 wt%, more preferably 70 to 87.5 wt%, even more preferably 75 to 85 wt%, and most preferably 79 to 81 wt%) of structural units of a carbosiloxane monomer of formula (I), based on the weight of the carbosiloxane-rich stage; [ka] In the formula, a is 0 to 3 (preferably 0 to 2, most preferably 1), d is 0 or 1 (preferably 0), and each R 1 are independently hydrogen, C 1~10 Alkyl groups, and aryl groups (preferably hydrogen, and C 1~10 Alkyl groups, more preferably hydrogen, and C 1~4 alkyl groups, even more preferably hydrogen, and methyl groups, most preferably methyl groups, and each R 2 are independently hydrogen, and C 1~10Alkyl groups (preferably hydrogen and C 1~5 Alkyl groups, more preferably hydrogen, and C 1~4 alkyl groups, even more preferably hydrogen, and methyl groups, most preferably methyl groups, and each R 8 is a —O—Si(CH3)3 group, and Y is selected from the group consisting of formulas (II), (III), and (IV) (preferably (II) or (III), most preferably (II)); [ka] In the formula, each R 4 and R 6 are independently selected from the group consisting of hydrogen and a methyl group (preferably a methyl group), and each R 3 and R 5 independently, C 1~10 Alkylene group (preferably C 1~7 Alkylene groups, more preferably C 2~6 Alkylene groups, even more preferably C 3~5 an alkylene group, most preferably a C alkylene group (e.g., —CH—CH—CH—), and each R 7 independently, C 1~10 is an alkyl group, b is 0 to 4, c is 0 or 1, and the first carbosiloxane monomer of Formula (I) and the second carbosiloxane monomer of Formula (I) are the same or different (preferably, the first carbosiloxane monomer of Formula (I) and the second carbosiloxane monomer of Formula (I) are the same) (preferably, the multi-stage polymer is an emulsion polymer) (preferably, the multi-stage polymer is an emulsion polymer comprising an acrylate-rich stage as the first stage and a carbosiloxane-rich stage as the second stage).

[0016] Preferably, the multi-stage polymers of the present invention comprise acrylate-rich stages. More preferably, the multi-stage polymers of the present invention comprise 60 to 95 wt% (preferably 65 to 90 wt%, more preferably 70 to 85 wt%, preferably 75 to 82 wt%) acrylate-rich stages based on the weight of the multi-stage polymer. Most preferably, the multi-stage polymer of the present invention comprises 60 to 95 wt % (preferably 65 to 90 wt %, more preferably 70 to 85 wt %, preferably 75 to 82 wt %) of an acrylate-rich stage, based on the weight of the multi-stage polymer, wherein the acrylate-rich stage comprises from 38 to less than 100 wt % (preferably 44 to 99.39 wt %, more preferably greater than 77 to 98.73 wt %, even more preferably 78.9 to 97.95 wt %, most preferably 82.17 to 94.68 wt %) of monoethylenically unsaturated nonionic acrylate-rich stage monomer structural units, based on the weight of the acrylate-rich stage, wherein the monoethylenically unsaturated nonionic acrylate-rich stage monomer is 1~22 and from 0 to 50 wt. % (preferably from 0.1 to 50 wt. %, more preferably from 0.5 to less than 20 wt. %, even more preferably from 1 to 19 wt. %, and most preferably from 4 to 16 wt. %) of structural units of a first carbosiloxane monomer of formula (I) based on the weight of the acrylate-rich stage, and from 0 to 10 wt. % (preferably from 0.5 to 5 wt. %, more preferably from 0.75 to 2.5 wt. %, and even more preferably from 1 to 20 wt. %, and most preferably from 4 to 16 wt. %) of structural units of a first carbosiloxane monomer of formula (I) based on the weight of the acrylate-rich stage. and 0 to 2 wt. % (preferably 0.01 to 1 wt. %, more preferably 0.02 to 0.5 wt. %, even more preferably 0.05 to 0.1 wt. %, most preferably 0.07 to 0.08 wt. %), based on the weight of the acrylate-rich stage, of structural units of a polyethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule.

[0017] Preferably, the acrylate-rich stage comprises 63 to 99.9 wt. % (preferably greater than 74 to 98.49 wt. %, more preferably 80.4 to 96.95 wt. %, and most preferably 82.17 to 94.68 wt. %) of structural units of the monoethylenically unsaturated nonionic acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, and the monoethylenically unsaturated nonionic acrylate-rich stage monomer is selected from the group consisting of C 1~22 More preferably, the acrylate-rich stage comprises from 63 to 99.9 wt. % (preferably from greater than 74 to 98.49 wt. %, more preferably from 80.4 to 96.95 wt. %, and most preferably from 82.17 to 94.68 wt. %) of structural units of the monoethylenically unsaturated nonionic acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, and the monoethylenically unsaturated nonionic acrylate-rich stage monomer comprises at least two C 1~8 More preferably, the acrylate-rich stage comprises from 63 to 99.9 wt. % (preferably from greater than 74 to 98.49 wt. %, more preferably from 80.4 to 96.95 wt. %, and most preferably from 82.17 to 94.68 wt. %) of structural units of the monoethylenically unsaturated nonionic acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, and the monoethylenically unsaturated nonionic acrylate-rich stage monomer comprises at least two C 1~4 Even more preferably, the acrylate-rich stage comprises from 63 to 99.9 wt. % (preferably from greater than 74 to 98.49 wt. %, more preferably from 80.4 to 96.95 wt. %, and most preferably from 82.17 to 94.68 wt. %) of structural units of the monoethylenically unsaturated nonionic acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, and the monoethylenically unsaturated nonionic acrylate-rich stage monomer is selected from the group consisting of at least three C 1~4Most preferably, the acrylate-rich stage comprises from 63 to 99.9 wt. % (preferably from greater than 74 to 98.49 wt. %, more preferably from 80.4 to 96.95 wt. %, and most preferably from 82.17 to 94.68 wt. %) of structural units of the monoethylenically unsaturated nonionic acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, and the monoethylenically unsaturated nonionic acrylate-rich stage monomer comprises at least three C 1~4 The alkyl (meth)acrylate is selected from the group consisting of a mixture of alkyl (meth)acrylates, the mixture including butyl acrylate, butyl methacrylate, and methyl methacrylate.

[0018] Preferably, the acrylate-rich stage comprises from greater than 0 to 50 wt% (preferably from 0.1 to 50 wt%, more preferably from 0.5 to less than 20 wt%, even more preferably from 1 to 19 wt%, and most preferably from 4 to 16 wt%) of a first carbosiloxane monomer of formula (I), based on the weight of the acrylate-rich stage. More preferably, the acrylate-rich stage comprises from greater than 0 to 50 wt% (preferably from 0.1 to 50 wt%, more preferably from 0.5 to less than 20 wt%, even more preferably from 1 to 19 wt%, and most preferably from 4 to 16 wt%) of a first carbosiloxane monomer of formula (I), based on the weight of the acrylate-rich stage, where a is from 0 to 3 (preferably from 0 to 2, and most preferably 1), d is 0 or 1 (preferably 0), and each R 1 are independently hydrogen, C 1~10 Alkyl groups, and aryl groups (preferably hydrogen, and C 1~10 Alkyl groups, more preferably hydrogen, and C 1~4 alkyl groups, even more preferably hydrogen, and methyl groups, most preferably methyl groups, and each R 2 are independently hydrogen, and C 1~10 Alkyl groups (preferably hydrogen and C 1~5 Alkyl groups, more preferably hydrogen, and C 1~4alkyl groups, even more preferably hydrogen, and methyl groups, most preferably methyl groups, and each R 8 is a —O—Si(CH3)3 group, Y is selected from the group consisting of formulas (II), (III), and (IV) (preferably (II) or (III), more preferably (II)), and each R 4 and R 6 are independently selected from the group consisting of hydrogen and a methyl group (preferably a methyl group), and each R 3 and R 5 independently, C 1~10 Alkylene groups (preferably C 1~7 Alkylene groups, more preferably C 2~6 Alkylene groups, even more preferably C 3~5 an alkylene group, most preferably a C alkylene group (e.g., —CH—CH—CH—), and each R 7 independently, C 1~10 is an alkyl group, b is 0 to 4, and c is 0 or 1. Most preferably, the carbosiloxane-rich stage comprises from greater than 0 to 50 wt. % (preferably 0.1 to 50 wt. %, more preferably 0.5 to less than 20 wt. %, even more preferably 1 to 19 wt. %, and most preferably 4 to 16 wt. %) of structural units of a first carbosiloxane monomer of formula (I), based on the weight of the acrylate-rich stage, where a is 1, d is 0, and each R 1 is a methyl group, and each R 2 is a methyl group and Y is of formula (II), wherein each R 3 is C 3~5 is an alkylene group, and each R 4 is a methyl group.

[0019] Preferably, the acrylate-rich stage comprises 0 to 10 wt. % (preferably 0.5 to 5 wt. %, more preferably 0.75 to 2.5 wt. %, even more preferably 1 to 2 wt. %, and most preferably 1.25 to 1.75 wt. %) of structural units of a monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer, based on the weight of the acrylate-rich stage. More preferably, the acrylate-rich stage comprises 0 to 10 wt. % (preferably 0.5 to 5 wt. %, more preferably 0.75 to 2.5 wt. %, even more preferably 1 to 2 wt. %, and most preferably 1.25 to 1.75 wt. %), based on the weight of the acrylate-rich stage, of structural units of a monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer, wherein the monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer is selected from the group consisting of (meth)acrylic acid, (meth)acryloxypropionic acid, itaconic acid, aconitic acid, maleic acid, maleic anhydride, fumaric acid, crotonic acid, citraconic acid, maleic anhydride, monomethyl maleate, monomethyl fumarate, monomethyl itaconate, other derivatives (e.g., the corresponding anhydrides, amides, and esters), and mixtures thereof. Even more preferably, the acrylate-rich stage comprises 0 to 10 wt. % (preferably 0.5 to 5 wt. %, more preferably 0.75 to 2.5 wt. %, even more preferably 1 to 2 wt. %, and most preferably 1.25 to 1.75 wt. %) structural units of a monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, wherein the monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer is selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid, and mixtures thereof. Even more preferably, the acrylate-rich stage comprises 0 to 10 wt. % (preferably 0.5 to 5 wt. %, more preferably 0.75 to 2.5 wt. %, even more preferably 1 to 2 wt. %, and most preferably 1.25 to 1.75 wt. %) of structural units of a monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, wherein the monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer is selected from the group consisting of at least one of acrylic acid and methacrylic acid.Most preferably, the acrylate-rich stage comprises 0 to 10 wt. % (preferably 0.5 to 5 wt. %, more preferably 0.75 to 2.5 wt. %, even more preferably 1 to 2 wt. %, and most preferably 1.25 to 1.75 wt. %) structural units of a monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer, based on the weight of the acrylate-rich stage, and the monoethylenically unsaturated carboxylic acid acrylate-rich stage monomer is methacrylic acid.

[0020] Preferably, the acrylate-rich stage comprises 0 to 2 wt. % (preferably 0.01 to 1 wt. %, more preferably 0.05 to 0.1 wt. %, and most preferably 0.07 to 0.08 wt. %), based on the weight of the acrylate-rich stage, of structural units of a multi-ethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule. More preferably, the acrylate-rich stage comprises 0 to 2 wt. % (preferably 0.01 to 1 wt. %, more preferably 0.05 to 0.1 wt. %, and most preferably 0.07 to 0.08 wt. %), based on the weight of the acrylate-rich stage, of structural units of a multi-ethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule, wherein the multi-ethylenically unsaturated monomer having at least two ethylenically unsaturated groups per molecule is selected from the group consisting of divinylaromatic compounds, di-(meth)acrylate esters, tri-(meth)acrylate esters, tetra-(methacrylate) esters, di-allyl ethers, tri-allyl ethers, tetra-allyl ethers, di-allyl esters, tri-allyl esters, tetra-allyl esters, allyl (meth)acrylates, and mixtures thereof.Even more preferably, the acrylate-rich stage comprises 0 to 2 wt. % (preferably 0.01 to 1 wt. %, more preferably 0.05 to 0.1 wt. %, and most preferably 0.07 to 0.08 wt. %), based on the weight of the acrylate-rich stage, of structural units of a multi-ethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule, the multi-ethylenically unsaturated monomer having at least two ethylenically unsaturated groups per molecule being selected from the group consisting of divinylbenzene (DVB), trimethylolpropane diallyl ether, tetra-allyl phenylpropane (TPA), methylpropane diphenyl ether (MPD), methylpropane diphenyl ether (MPE ... The copolymer is selected from the group consisting of dimethicone, thiaerythritol, triallyl pentaerythritol, diallyl pentaerythritol, diallyl phthalate, diallyl maleate, triallyl cyanurate, bisphenol A diallyl ether, allyl sucrose, methylene bisacrylamide, trimethylolpropane triacrylate, allyl methacrylate (ALMA), ethylene glycol dimethacrylate (EGDMA), hexane-1,6-diol diacrylate (HDDA), butylene glycol dimethacrylate (BGDMA), and mixtures thereof. Even more preferably, the acrylate-rich stage comprises 0 to 2 wt. % (preferably 0.01 to 1 wt. %, more preferably 0.05 to 0.1 wt. %, and most preferably 0.07 to 0.08 wt. %), based on the weight of the acrylate-rich stage, of structural units of a multi-ethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule, wherein the multi-ethylenically unsaturated monomer having at least two ethylenically unsaturated groups per molecule is selected from the group consisting of DVB, ALMA, EGDMA, HDDA, and BGDMA. Even more preferably, the acrylate-rich stage comprises 0 to 2 wt. % (preferably 0.01 to 1 wt. %, more preferably 0.05 to 0.1 wt. %, and most preferably 0.07 to 0.08 wt. %), based on the weight of the acrylate-rich stage, of structural units of a multi-ethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule, wherein the multi-ethylenically unsaturated monomer having at least two ethylenically unsaturated groups per molecule comprises ALMA.Most preferably, the acrylate-rich stage comprises 0 to 2 wt. % (preferably 0.01 to 1 wt. %, more preferably 0.05 to 0.1 wt. %, and most preferably 0.07 to 0.08 wt. %), based on the weight of the acrylate-rich stage, of structural units of a multi-ethylenically unsaturated acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule, wherein the multi-ethylenically unsaturated monomer having at least two ethylenically unsaturated groups per molecule is ALMA.

[0021] Preferably, the multi-stage polymers of the present invention comprise carbosiloxane-rich stages. More preferably, the multi-stage polymers of the present invention comprise from 5 to 40% by weight (preferably from 10 to 35%, more preferably from 15 to 30%, preferably from 18 to 25%) of carbosiloxane-rich stages based on the weight of the multi-stage polymer. Most preferably, the multi-stage polymers of the present invention comprise from 5 to 40% by weight (preferably from 10 to 35%, more preferably from 15 to 30%, and preferably from 18 to 25%) of carbosiloxane-rich stages, based on the weight of the multi-stage polymer, the carbosiloxane-rich stages comprising from 0 to 90% by weight (preferably from 10 to less than 50%, more preferably from 12.5 to 30%, even more preferably from 15 to 25%, and most preferably from 19 to 21%) of structural units of a vinyl monomer, based on the weight of the carbosiloxane-rich stages, and from 10 to 100% by weight (preferably from greater than 50 to 90%, more preferably from 70 to 87.5%, even more preferably from 75 to 85%, and most preferably from 79 to 81%) of structural units of a second carbosiloxane monomer of formula (I), based on the weight of the carbosiloxane-rich stages.

[0022] Preferably, the carbosiloxane-rich stage comprises 0 to 90 wt. % (preferably 10 to less than 50 wt. %, more preferably 12.5 to 30 wt. %, even more preferably 15 to 25 wt. %, and most preferably 19 to 21 wt. %) of structural units of a vinyl monomer, based on the weight of the carbosiloxane-rich stage. More preferably, the carbosiloxane-rich stage comprises 0 to 90 wt. % (preferably 10 to less than 50 wt. %, more preferably 12.5 to 30 wt. %, even more preferably 15 to 25 wt. %, and most preferably 19 to 21 wt. %) of structural units of a vinyl monomer, based on the weight of the carbosiloxane-rich stage, the vinyl monomer containing at least one radically polymerizable vinyl group per molecule. Even more preferably, the carbosiloxane-rich stage comprises 0 to 90 wt. % (preferably 10 to less than 50 wt. %, more preferably 12.5 to 30 wt. %, even more preferably 15 to 25 wt. %, and most preferably 19 to 21 wt. %) of structural units of a vinyl monomer, based on the weight of the carbosiloxane-rich stage, the vinyl monomer being selected from the group consisting of C 1~3 Alkyl acrylates (e.g., methyl acrylate, ethyl acrylate, n-propyl acrylate, isopropyl acrylate), C 1~3 Alkyl methacrylates (e.g., methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, isopropyl methacrylate), monoethylenically unsaturated carboxylic acids (e.g., (meth)acrylic acid, (meth)acryloxypropionic acid, itaconic acid, aconitic acid, maleic acid, maleic anhydride, fumaric acid, crotonic acid, citraconic acid, maleic anhydride, monomethyl maleate, monomethyl fumarate, monomethyl itaconate), C 4~20 Alkyl acrylates (e.g., n-butyl acrylate, isobutyl acrylate, tert-butyl acrylate, n-hexyl acrylate, cyclohexyl acrylate, 2-ethylhexyl acrylate, octyl acrylate, lauryl acrylate, stearyl acrylate), C 4~20The alkyl methacrylate may be selected from the group consisting of alkyl methacrylates (e.g., n-butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate, n-hexyl methacrylate, cyclohexyl methacrylate, 2-ethylhexyl methacrylate, octyl methacrylate, lauryl methacrylate, stearyl methacrylate), aromatic vinyl monomers (e.g., styrene, vinyl toluene, benzyl acrylate, benzyl methacrylate, phenoxyethyl acrylate, phenoxyethyl methacrylate, vinyl pyrrolidone), and mixtures thereof. Even more preferably, the carbosiloxane-rich stage comprises 0 to 90 wt. % (preferably 10 to less than 50 wt. %, more preferably 12.5 to 30 wt. %, even more preferably 15 to 25 wt. %, and most preferably 19 to 21 wt. %) of structural units of a vinyl monomer, based on the weight of the carbosiloxane-rich stage, the vinyl monomer being selected from the group consisting of methyl acrylate, ethyl acrylate, n-propyl acrylate, isopropyl acrylate, methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, isopropyl methacrylate, n-butyl acrylate, isobutyl acrylate, tert-butyl acrylate, n-hexyl acrylate, cyclohexyl acrylate, 2-ethylhexyl acrylate, n-butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate, n-hexyl methacrylate, 2-ethylhexyl methacrylate, methacrylic acid, and mixtures thereof. Most preferably, the carbosiloxane-rich stage comprises 0 to 90 wt. % (preferably 10 to less than 50 wt. %, more preferably 12.5 to 30 wt. %, even more preferably 15 to 25 wt. %, and most preferably 19 to 21 wt. %) of structural units of vinyl monomers, based on the weight of the carbosiloxane-rich stage, the vinyl monomers comprising methyl methacrylate and methacrylic acid.

[0023] Preferably, the carbosiloxane-rich stage comprises 10 to 100 wt. % (preferably greater than 50 to 90 wt. %, more preferably 70 to 87.5 wt. %, even more preferably 75 to 85 wt. %, and most preferably 79 to 81 wt. %), based on the weight of the carbosiloxane-rich stage, of structural units of the second carbosiloxane monomer of formula (I). More preferably, the carbosiloxane-rich stage comprises 10 to 100 wt. % (preferably greater than 50 to 90 wt. %, more preferably 70 to 87.5 wt. %, even more preferably 75 to 85 wt. %, and most preferably 79 to 81 wt. %), based on the weight of the carbosiloxane-rich stage, of structural units of the second carbosiloxane monomer of formula (I), where a is 0 to 3 (preferably 0 to 2, more preferably 1), d is 0 or 1 (preferably 0), and R 1 are independently hydrogen, C 1~10 Alkyl groups, and aryl groups (preferably hydrogen, and C 1~10 Alkyl groups, more preferably hydrogen, and C 1~4 alkyl groups, even more preferably hydrogen, and methyl groups, most preferably methyl groups, and each R 2 are independently hydrogen, and C 1~10 Alkyl groups (preferably hydrogen and C 1~5 Alkyl groups, more preferably hydrogen, and C 1~4 alkyl groups, even more preferably hydrogen, and methyl groups, most preferably methyl groups, and each R 8 is a —O—Si(CH3)3 group, Y is selected from the group consisting of formulas (II), (III), and (IV) (preferably (II) or (III), most preferably (II)), and each R 4 and R 6 are independently selected from the group consisting of hydrogen and a methyl group (preferably a methyl group), and each R 3 and R 5 independently, C 1~10 Alkylene groups (preferably C 1~7 Alkylene groups, more preferably C 2~6 Alkylene groups, even more preferably C 3~5an alkylene group, most preferably a C alkylene group (e.g., —CH—CH—CH—), and each R 7 independently, C 1~10 is an alkyl group, b is 0 to 4, and c is 0 or 1. Most preferably, the carbosiloxane-rich stage comprises 10 to 100 wt. % (preferably greater than 50 to 90 wt. %, more preferably 70 to 87.5 wt. %, even more preferably 75 to 85 wt. %, and most preferably 79 to 81 wt. %), based on the weight of the carbosiloxane-rich stage, of structural units of the second carbosiloxane monomer of formula (I), where a is 1, d is 0, and each R 1 is a methyl group, and each R 2 is a methyl group and Y is of formula (II), wherein each R 3 is C 3~5 is an alkylene group, and each R 4 is a methyl group.

[0024] Preferably, the compositions of the present invention comprise a multi-stage polymer of the present invention. More preferably, the compositions of the present invention comprise 0.1 to 10% by weight (preferably 0.5 to 7.5%, more preferably 1 to 7%, even more preferably 3 to 6%, and most preferably 4 to 5%) of the multi-stage polymer of the present invention based on the weight of the personal care formulation. Most preferably, the compositions of the present invention comprise 0.1 to 10% by weight (preferably 0.5 to 7.5%, more preferably 1 to 7%, even more preferably 3 to 6%, and most preferably 4 to 5%) of the multi-stage polymer of the present invention based on the weight of the personal care formulation, the multi-stage polymer comprising an acrylate-rich stage and a carbosiloxane-rich stage.

[0025] Preferably, the compositions of the present invention are selected from the group consisting of personal care formulations (e.g., hair care formulations, skin care formulations, sun care formulations, nail care formulations, pet care formulations, antiperspirant / deodorant formulations, color cosmetic formulations), home care formulations, coatings, oil field maintenance fluids, civil engineering maintenance fluids, construction formulations, and pharmaceutical preparations.

[0026] Preferably, the composition of the present invention further comprises a carrier. More preferably, the composition of the present invention comprises 0.1 to 99.9% by weight (preferably 10 to 95% by weight, more preferably 25 to 90% by weight, more preferably 40 to 80% by weight) of the carrier based on the weight of the composition. Most preferably, the composition of the present invention comprises 0.1 to 99.9% by weight (preferably 10 to 95% by weight, more preferably 25 to 90% by weight, more preferably 40 to 80% by weight) of the carrier based on the weight of the composition, and the multistage polymer is dispersed in the carrier.

[0027] Preferably, the composition of the present invention further comprises 0.1 to 99.9 wt % (preferably 10 to 95 wt %, more preferably 25 to 90 wt %, more preferably 40 to 80 wt %) of a carrier based on the weight of the composition, and the carrier is water, an emulsion (e.g., an oil-in-water emulsion, a water-in-oil emulsion), an alcohol (e.g., C 1~4 The carrier is selected from the group consisting of straight-chain or branched-chain alcohols (e.g., ethyl alcohol, propyl alcohol, isopropyl alcohol, butyl alcohol), glycols (e.g., ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol, ethoxydiglycol), glycerin, butyl cellosolve, and mixtures thereof. More preferably, the composition of the present invention comprises 0.1 to 99.9% by weight (preferably 10 to 95% by weight, more preferably 25 to 90% by weight, more preferably 40 to 80% by weight) of a carrier, and the carrier comprises water.

[0028] Preferably, the compositions of the present invention are personal care formulations. More preferably, the compositions of the present invention are personal care formulations selected from the group consisting of hair care formulations, skin care formulations, sun care formulations, nail care formulations, pet care formulations, antiperspirant / deodorant formulations, and color cosmetic formulations. Preferably, the compositions of the present invention are personal care formulations selected from the group consisting of hair care formulations, skin care formulations, sun care formulations, nail care formulations, pet care formulations, antiperspirant / deodorant formulations, and color cosmetic formulations, wherein the personal care formulation further comprises a cosmetically acceptable carrier, wherein the cosmetically acceptable carrier is selected so that the personal care formulation can evaporate upon application to mammalian skin and / or hair.

[0029] Preferably, the composition of the present invention is a personal care formulation, wherein the personal care formulation further comprises at least one personal care active selected from the group consisting of waterproofing agents, emollients, preservatives, antioxidants, fragrances, deodorants, antiperspirant actives, skin cooling agents, moisturizers, rheology modifiers, aesthetic modifiers, vitamins, skin protectants, oils, emulsifiers, surfactants, pearlizing agents, consistency factors, thickeners, superfatting agents, stabilizers, polymers, silicone oils, fats, waxes, lecithin, phospholipids, fillers, light management powders or particles, moisturizers, cleansers, sun care actives, hair treatment actives, anti-dandruff agents, colorants, and skin care actives.

[0030] Preferably, the composition of the present invention is a coating. More preferably, the composition of the present invention is a coating, which further comprises at least one coating component selected from the group consisting of a film-forming binder, an opacifier, a pigment, a rheology modifier, a wetting agent, and a metal oxide.

[0031] Preferably, the composition of the present invention is a home care formulation. More preferably, the composition of the present invention is a home care formulation, the home care formulation further comprising at least one home care active ingredient selected from the group consisting of air fresheners, insect repellents, deodorizers, cleaning agents, disinfectants, laundry detergents, laundry softeners, dishwashing detergents, toilet bowl cleaners, fabric sizes, lubricants, and textile wipes.

[0032] Preferably, the composition of the present invention is an oilfield servicing fluid. More preferably, the composition of the present invention is an oilfield servicing fluid, the oilfield servicing fluid further comprising at least one of clay, xanthan gum, starch, a polymer, an acid-soluble carbonate, sodium chloride, and a rheology modifier.

[0033] Preferably, the composition of the present invention is a construction formulation. More preferably, the composition of the present invention is a construction formulation, the construction formulation further comprising at least one of cement, concrete, adhesive, plaster, mortar, jointing compound, clay, and mica.

[0034] Preferably, the composition of the present invention is a pharmaceutical formulation. More preferably, the composition of the present invention is a pharmaceutical formulation. The pharmaceutical formulation further comprises a pharmaceutically acceptable carrier, and the pharmaceutically acceptable carrier is selected so that the pharmaceutical formulation can evaporate upon application to mammalian tissue or hair.

[0035] Preferably, the composition of the present invention is a pharmaceutical formulation, which further comprises at least one of an excipient, a biologically active agent, a tableting material, an inactive ingredient, a binder, a sustained release agent, a flavoring agent, and a coloring agent.

[0036] The multi-stage polymers of the present invention can be prepared by conventional polymerization techniques, such as emulsion polymerization. Aqueous emulsion polymerization processes are typically carried out in an aqueous reaction mixture containing at least one monomer and various synthetic adjuvants, such as a free radical source, a buffer, a chain transfer agent, and a reducing agent, in an aqueous reaction medium. Preferably, the multi-stage polymers of the present invention are emulsion polymers. More preferably, the multi-stage polymers of the present invention are emulsion polymers, with the acrylate-rich stage being the first stage of the emulsion polymer and the carboxyloxane-rich stage being the second stage of the emulsion polymer.

[0037] Some embodiments of the present invention will now be described in detail in the following examples.

[0038] The abbreviations for the monomers used in the examples are listed in Table 1. [Table 1]

[0039] Example SC: Multistage Polymer A 2-liter round-bottom flask (equipped with an overhead stirrer, thermocouple, condenser, and inlets for adding monomer and initiator) was charged with deionized water (262.0 g), 50% CAVASOL™ W7 MTL (a cyclodextrin from Wacker Fine Chemicals) (15.2 g), 31.5% Aerosol™ A102 surfactant (from Solvay) (20.5 g), and sodium carbonate (3.4 g). The contents of the flask were stirred and heated to 85° C.

[0040] An acrylate-rich monomer emulsion was prepared by placing deionized water (294.9 g) and 31.5% Aerosol™ A102 surfactant (8.7 g) in a first vessel and setting it to agitation. Once the surfactant was incorporated into the water, the following monomers were added slowly to the first vessel with continued agitation: BA (182.4 g), BMA (264.5 g), MMA (152.0 g), MAA (9.1 g), and ALMA (0.5 g).

[0041] A carbosiloxane-rich monomer emulsion was prepared by placing deionized water (76.0 g) and 31.5% Aerosol™ A102 surfactant (2.2 g) in a second container and setting it to agitation. Once the surfactant was incorporated into the water, the following monomers were slowly added to the second container with continued agitation: MD'M-ALMA (121.6 g), MMA (28.1 g), and MAA (2.3 g). The carbosiloxane-rich monomer emulsion was further emulsified using homogenization at 7,000 rpm for 10 minutes.

[0042] A cofeed catalyst solution was prepared containing sodium persulfate (1.5 g) and deionized water (40.3 g).

[0043] A cofeed buffer solution was prepared containing sodium carbonate (1.5 g) and deionized water (40.3 g).

[0044] At a reaction set temperature of 85°C, 34.2 g of the acrylate-rich monomer emulsion from the first vessel was charged to the contents of the flask, along with a deionized water rinse (15.2 g). An initiator solution of sodium persulfate (3.4 g) in deionized water (15.2 g) was then added to the contents of the flask. After the initial polymerization, the remainder of the acrylate-rich monomer emulsion in the first vessel was co-fed to the contents of the flask at a rate of 6.05 g / min for 15 minutes, then at a rate of 13.01 g / min for 60 minutes. Simultaneously with the co-feed of the acrylate-rich monomer emulsion, a co-feed catalyst solution and a co-feed buffer solution were added to the reactor contents at a rate of 0.44 g / min for 95 minutes.

[0045] Following the addition of the acrylate-rich monomer emulsion, the carbosiloxane-rich monomer emulsion in the second vessel was added to the reactor contents at a rate of 11.51 g / min over a period of 20 minutes. After completion of the various feeds, the contents of the flask were monitored to reduce the amount of residual monomer to yield the product multi-stage polymer. Examples S1 to S4: Multistage Polymers

[0046] Multistage polymers were prepared substantially as described in Example SC, with appropriate variations made using the acrylate-rich stage monomers and carbosiloxane-rich stage monomers in each stage, as described in Table 2, to reflect the total weight percent of the acrylate-rich stage and carbosiloxane-rich stage in each multistage polymer of Examples S1-S4. [Table 2]

[0047] Polymer properties The product multistage polymers prepared according to Comparative Example SC and Examples S1-S4 were analyzed for percent solids, pH, average particle size (using a Brookhaven Instruments BI-90 particle size analyzer), and glass transition temperature T measured using a TA Instruments Model 2920 Differential Scanning Calorimeter (DSC). gThe results are shown in Table 3. [Table 3]

[0048] Mechanical properties of neat polymer films The mechanical properties of the films were evaluated by tensile testing to determine the tensile strength, toughness, and flexibility of the films. Neat polymer films were prepared by casting 20 g of each of the polymers produced according to Comparative Example SC and Examples S1-S4 into a 9.4 cm diameter Petri dish. The polymer latex was air-dried in an environmentally controlled room (72°F, 50% RH) until a dry film was formed. The dried film was then peeled from the Petri dish and cut into three dogbone pieces with a neck portion measuring 0.75 inches long and 0.25 inches wide. The dogbone pieces were then tested using an Instron 5565 tensile tester at an extension rate of 10 inches / minute in an environmentally controlled room (72°F, 50% RH). The tensile test results are shown in Table 4. [Table 4]

[0049] Water- and oil-repellent The water and sebum repellency of a film is governed by surface energy. High long-term water and sebum repellency is desired in various applications, such as architectural coatings and personal care applications (i.e., providing long-term active deposition and abrasion resistance benefits, particularly in color cosmetics, sunscreens, and pollution control products). Water and sebum repellency can be evaluated by measuring the water and sebum contact angles from the film surface. Specifically, films were prepared from the multistage polymers of the products prepared according to Comparative Example SC and Examples S1-S4 by drawdown using a 3-mil or 6-mil doctor blade on a black plastic chart (available from LENETA P121-16). The drawn films were air-dried in an environmentally controlled room (72°F and 50% RH) for at least 72 hours. The dried films were then placed in a fog box for at least 48 hours to remove residual surfactant from the film surface. After treatment in the fog box, the films were allowed to air dry in an environmentally controlled room (72°F and 50% RH) for at least 24 hours before measurements were taken. After depositing a droplet of water or sebum onto the substrate using a drop shape analyzer (Kruss DSA100), both the water contact angle and the sebum contact angle were measured at approximately 4 seconds and 250 seconds. For the sebum contact angle measurements, an artificial sebum solution was prepared having the composition listed in Table 5. The results of the water contact angle and sebum contact angle measurements are shown in Table 6. [Table 5] [Table 6]

[0050] Formulation Example G1: Generic Color Cosmetic Formulation A color cosmetic formulation having a generic formulation was prepared according to Formulation Example G1 set forth in Table 7. The ingredients of Phase A were added to a beaker and mixed until uniform. The ingredients of Phase B were then slowly added to the contents of the beaker while mixing until uniform. The ingredients of Phase C were combined in a separate container and then slowly added to the contents of the beaker while mixing until uniform. The test polymer of Phase D was then slowly added to the contents of the beaker while mixing until uniform. The ingredients of Phase E were then added to the contents of the beaker while mixing until uniform. The ingredients of Phase F were then added to the contents of the beaker. The contents of the beaker were then mixed until uniform to provide the product color cosmetic formulation. [Table 7]

[0051] Comparative Examples C1-C3 and Examples 1-4: Color Cosmetic Formulations The color cosmetic formulations of Comparative Examples C1-C3 and Examples 1-4 were prepared according to Formulation Example G1 using various test polymers as listed in Table 8.

[0052] Abrasion resistance The color cosmetic formulations prepared according to Comparative Examples C1-C3 and Examples 1-4 were each coated onto a white vinyl chart (available from Leneta) using a doctor blade film applicator set at a gap of 6 mil (0.1524 mm) and allowed to dry at 22°C for at least 24 hours. The color readings of each sample were then measured using a BYK-Gardner color spectrophotometer. The abrasion resistance of the deposited films of the color cosmetic formulations was characterized by the change in color (ΔE) before and after abrasion on pre-cut bath towels (55 mm x 45 mm). The bath towels were fixed to the moving part of a robot that periodically moved back and forth at a constant speed. The films were abraded by the bath towels under a pressure of approximately 600 Pa through three abrasion cycles, each lasting 6 seconds. Readings were taken from 10 points on each deposited film. The average of the 10 readings from each film is shown in Table 8.

Table 8

Claims

1. A multi-stage polymer comprising: (a) 60 to 95 weight percent acrylate-rich stages, based on the weight of said multi-stage polymer; 38 to less than 100 wt. % based on the weight of the (a) acrylate-rich stage, 1~22 monoethylenically unsaturated nonionic structural units of the (a) acrylate-rich stage monomer selected from the group consisting of alkyl (meth)acrylates and mixtures thereof; (a) from greater than 0 to 50 wt. %, based on the weight of the acrylate-rich stage, of structural units of a first carbosiloxane monomer of formula (I): 【Chemical 1】 0 to 10 wt. %, based on the weight of the (a) acrylate-rich stage, of structural units of the (a) acrylate-rich stage monomer of a monoethylenically unsaturated carboxylic acid; an (a) acrylate-rich stage comprising: 0 to 2 weight percent, based on the weight of the (a) acrylate-rich stage, of structural units of a multi-ethylenically unsaturated (a) acrylate-rich stage monomer having at least two ethylenically unsaturated groups per molecule; (b) 5 to 40 weight percent carbosiloxane-rich stage, based on the weight of said multi-stage polymer; (b) from 0 to less than 50 weight percent, based on the weight of the carbosiloxane-rich stage, of structural units of a vinyl monomer other than the second carbosiloxane monomer of formula (I); and (b) a carbosiloxane-rich stage comprising: greater than 50 to 100 weight percent, based on the weight of the (b) carbosiloxane-rich stage, structural units of a second carbosiloxane monomer of formula (I); 【Chemistry 2】 In the formula, a is 0 to 3, d is 0, and each R 1 are independently hydrogen, C 1~10 alkyl groups, and aryl groups, and each R 2 are independently hydrogen, and C 1~10 alkyl groups, and each R 8 is —O—Si(CH 3 ) 3 is a group, and Y is selected from the group consisting of formulas (II), and (IV), 【Chemistry 3】 In the formula, each R 4 and R 6 are independently selected from the group consisting of hydrogen and a methyl group; 3 and R 5 are independently 1~10 is an alkylene group, and each R 7 are independently 1~10 is an alkyl group, b is 0 to 4, and c is 0 or 1; A multi-stage polymer wherein said first carbosiloxane monomer of formula (I) and said second carbosiloxane monomer of formula (I) are the same or different.

2. A composition comprising the multistage polymer of claim 1 and a carrier.

3. The composition of claim 2 , wherein the carrier comprises water.

4. 4. The composition of claim 3, wherein the composition is selected from the group consisting of a personal care formulation, a home care formulation, a coating, an oil field maintenance fluid, a civil engineering maintenance fluid, a construction formulation, and a pharmaceutical preparation.

5. 5. The composition of claim 4, wherein the composition is a personal care formulation, the personal care formulation further comprising at least one personal care active selected from the group consisting of waterproofing agents, emollients, preservatives, antioxidants, fragrances, deodorants, antiperspirant actives, skin cooling agents, moisturizers, rheology modifiers, vitamins, skin protectants, oils, emulsifiers, surfactants, pearlescent agents, thickeners, stabilizers, silicone oils, fats, waxes, phospholipids, fillers, light management powders or particles, cleansers, sun care actives, hair treatment actives, anti-dandruff agents, and skin care actives.

6. 5. The composition of claim 4, wherein the composition is a coating, and the coating further comprises at least one coating component selected from the group consisting of a film-forming binder, an anti-sag agent, a leveling agent, a cure accelerator, an opacifier, a pigment, a rheology modifier, a wetting agent, and a metal oxide.

7. 5. The composition of claim 4, wherein the composition is a home care formulation, the home care formulation further comprising at least one home care active ingredient selected from the group consisting of a fragrance, an insect repellent, a deodorizer, a cleaning agent, a disinfectant, a laundry detergent, a laundry softener, a dishwashing detergent, a toilet bowl cleaner, a lubricant, and a textile wipe.

8. 5. The composition of claim 4, wherein the composition is an oilfield servicing fluid, the oilfield servicing fluid further comprising at least one of clay, xanthan gum, starch, acid soluble carbonate, sodium chloride, and a rheology modifier.

9. 5. The composition of claim 4, wherein the composition is a construction formulation, the construction formulation further comprising at least one of cement, concrete, adhesives, plaster, mortar, jointing compounds, and clay.

10. 5. The composition of claim 4, wherein the composition is a pharmaceutical formulation, the pharmaceutical formulation further comprising excipients, biologically active agents, tableting materials, binders, sustained release agents, flavoring agents, and coloring agents.

Citation Information

Patent Citations

  • Composite vinyl chloride resin material

    JP1985163908A

  • Graft polymer

    JP1987104826A

  • Cosmetic composition containing polymer particle dispersion, polymer particle dispersion and beauty method using the same

    JP2006225389A

  • Multistage polymer dispersion, method for producing the dispersion, and use of the dispersion

    JP2014506276A

  • JPP7536014B